Related Experiment Videos

Clinical markers and modifiable cardiovascular risk factors after kidney transplantation

M Arias¹, G Fernández-Fresnedo

¹Nephrology Service, Universitary Hospital Marqués de Valdecilla, Santander, Spain. nefarm@humv.es

Transplantation Proceedings

|December 26, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Unraveling effect pathways and biomagnification: The impact of a polyfluoroalkyl fungicide on an aquatic decomposer-detritivore system.

Ecotoxicology and environmental safety·2026

New-onset chronic and neuropathic pain in survivors of severe COVID-19: A secondary analysis of the PAIN-COVID Trial.

Revista espanola de anestesiologia y reanimacion·2025

Effectiveness of a specific follow up program for the management of the mental components of post-intensive care syndrome and chronic pain after COVID-19: results from the PAIN-COVID randomized clinical trial.

Revista espanola de anestesiologia y reanimacion·2024

High variability in Factor IX one-stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system.

International journal of laboratory hematology·2023

Autosomal recessive spinocerebellar ataxia SCAR8/ARCA1: first families detected in Spain.

Neurologia·2022

Indirect Immunoperoxidase Test (IPT) for Detection of Antibodies Against African Swine Fever Virus (ASFV) on African Green Monkey Cell Lines (Vero, MS).

Methods in molecular biology (Clifton, N.J.)·2022

See all related articles